Prof. George Birkmayer
Pioneer in NADH research and developer of stabilized NADH
Prof. George Birkmayer – Biochemist, Physician, and NADH Researcher
University Professor George Birkmayer, M.D., Ph.D. (1941–2022), was a biochemist and physician who worked in medical and biochemical research for decades.
After completing his scientific training and conducting research internationally, he devoted a significant portion of his life to studying NADH (nicotinamide adenine dinucleotide hydride), also known as coenzyme 1, and its role in human energy metabolism.
A particular focus of his work was on the practical applicability of the sensitive coenzyme NADH. In the early 1990s, Birkmayer developed a stabilized form of NADH, thereby laying an essential foundation for its use in oral products.
His research, publications, and decades of development work continue to form the scientific foundation of the work carried out by Prof. George Birkmayer NADH GmbH.
Prof. Birkmayer and NADH Research
Prof. George Birkmayer devoted a significant portion of his scientific work to NADH— the reduced form of the coenzyme nicotinamide adenine dinucleotide.
NADH plays a central role in cellular energy metabolism and in energy production in the mitochondria. For decades, Prof. Birkmayer conducted extensive research on NADH and its importance for the human body.
This scientific work led to numerous publications and research projects. Birkmayer later summarized his findings and experiences with NADH in his book *NADH—Biological Hydrogen: The Secret of Our Life Energy*.
The Breakthrough: Stabilized NADH
NADH is a sensitive coenzyme. A key challenge, therefore, was to stabilize NADH so that it could be used in oral products.
After years of research, Prof. George Birkmayer developed a stabilized form of NADH in the early 1990s. In 1994, a patent was granted in the United States for “Stable, ingestible, and absorbable NADH and NADPH therapeutic compositions”; a corresponding European patent followed.
This development laid an important foundation for the use of stabilized NADH in oral products and became a central component of Birkmayer's subsequent work with NADH.
Patents: US 5,332,727 (1994) · EP 0 697 859 B1 (1997)
Research and Publications on NADH
For decades, Prof. George Birkmayer conducted scientific research on NADH and its role in the human body.
As part of his research, he has produced numerous scientific publications and studies on NADH—including those on cellular energy metabolism and the application of NADH in various fields of research.
This scientific paper shaped Birkmayer's research on NADH over many years and constitutes an important part of his scientific legacy.
The Legacy of Prof. George Birkmayer
Prof. George Birkmayer devoted a significant portion of his life to researching NADH. His scientific work, publications, and developments form the foundation upon which Prof. George Birkmayer NADH GmbH is built today.
Following his death in 2022, we are continuing this work. In doing so, we are deliberately focusing on the molecule that was at the center of his decades of research: NADH.
This specialization continues to shape our company to this day—from the ongoing development of our products to our commitment to quality and scientific rigor.
This is how we combine Prof. George Birkmayer’s scientific work with our commitment to carrying his pioneering work forward into the future.
Our philosophy
100% LIFE
For us, 100% LIFE means being able to enjoy life as actively and independently as possible at every stage—even as we grow older.
It means not settling for less too quickly, but staying curious, active, and full of joy for life. Without making unnecessary compromises. And without having to give up the things that make your life special.
It is precisely for this reason that we focus 100% on high-quality NADH products. We rely on specialization, scientific expertise, and decades of experience—not on every new trend.
The focus is on a molecule that plays a central role in cellular energy metabolism and to whose study Prof. George Birkmayer has devoted a significant portion of his scientific career: NADH.
For 100% LIFE.
Our team
PROF. DR. DR. GEORGE BIRKMAYER
Founder & Pioneer of NADH Research (*1941–2022†)
RENE PFNEISZL
CEO | Management
Lisa Streibl (formerly Lisa Hager)
Marketing & Sales Management
Ahmed Aldallal
Head of R&D | Sales Arab region
Gabriele Sattler
Head of Procurement | Customer Service
Our sales partners
From our headquarters in Vienna, we distribute our NADH products worldwide. In addition, we work with experienced local distribution partners in select markets.
This is how we combine our expertise in NADH with local support and many years of market knowledge.
Prof. George Birkmayer